{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:39:47Z","timestamp":1774899587968,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/02162\u20138"],"award-info":[{"award-number":["2013\/02162\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/27198\u20138"],"award-info":[{"award-number":["2014\/27198\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/15800-6"],"award-info":[{"award-number":["2020\/15800-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00467-024-06643-8","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:12:01Z","timestamp":1738206721000},"page":"2741-2757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-8571","authenticated-orcid":false,"given":"Mara S.","family":"Guaragna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-1109","authenticated-orcid":false,"given":"Fernanda M. S.","family":"Casimiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2165-0761","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-0749","authenticated-orcid":false,"given":"Luciana","family":"de S. Feltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-2968","authenticated-orcid":false,"given":"Andreia","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-6763","authenticated-orcid":false,"given":"Precil D. M. M.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-632X","authenticated-orcid":false,"given":"Jo\u00e3o B.","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-5431","authenticated-orcid":false,"given":"Vera M. S.","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-9665","authenticated-orcid":false,"given":"Paulo C. K.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-5419","authenticated-orcid":false,"given":"Luiz F.","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"6643_CR1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/ctr.12825","volume":"30","author":"R Cleper","year":"2016","unstructured":"Cleper R, Krause I, Bar Nathan N et al (2016) Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years\u2019 experience. Clin Transplant 30:1324\u20131331. https:\/\/doi.org\/10.1111\/ctr.12825","journal-title":"Clin Transplant"},{"key":"6643_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","volume":"15","author":"MA Saleem","year":"2019","unstructured":"Saleem MA (2019) Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol 15:750\u2013765. https:\/\/doi.org\/10.1038\/s41581-019-0217-5","journal-title":"Nat Rev Nephrol"},{"key":"6643_CR3","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/S00467-022-05789-7","volume":"38","author":"ML Downie","year":"2023","unstructured":"Downie ML, Gupta S, Chan MMY et al (2023) Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome. Pediatr Nephrol 38:1793\u20131800. https:\/\/doi.org\/10.1007\/S00467-022-05789-7","journal-title":"Pediatr Nephrol"},{"key":"6643_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/S13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S et al (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481. https:\/\/doi.org\/10.1007\/S13312-021-2217-3","journal-title":"Indian Pediatr"},{"key":"6643_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/J.KINT.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J et al (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/J.KINT.2021.05.021","journal-title":"Kidney Int"},{"key":"6643_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/CJN.07370715","volume":"11","author":"AK B\u00fcscher","year":"2016","unstructured":"B\u00fcscher AK, Beck BB, Melk A et al (2016) Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11:245\u2013253. https:\/\/doi.org\/10.2215\/CJN.07370715","journal-title":"Clin J Am Soc Nephrol"},{"key":"6643_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato M, Er PX, Chiu HS et al (2015) Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526:564\u2013568. https:\/\/doi.org\/10.1038\/nature15695","journal-title":"Nature"},{"key":"6643_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0140-6736(72)91734-5","volume":"300","author":"JR Hoyer","year":"1972","unstructured":"Hoyer JR, Raij L, Vernier RL et al (1972) Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 300:343\u2013348. https:\/\/doi.org\/10.1016\/S0140-6736(72)91734-5","journal-title":"Lancet"},{"key":"6643_CR9","first-page":"255","volume":"20","author":"G Lagrue","year":"1991","unstructured":"Lagrue G, Branellec A, Niaudet P et al (1991) Transmission of nephrotic syndrome to two neonates. Spontaneous regression. Presse Med 20:255\u2013257","journal-title":"Presse Med"},{"key":"6643_CR10","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1056\/NEJMc1202500","volume":"366","author":"L Gallon","year":"2012","unstructured":"Gallon L, Leventhal J, Skaro A et al (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366:1648\u20131649. https:\/\/doi.org\/10.1056\/NEJMc1202500","journal-title":"N Engl J Med"},{"key":"6643_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000183469","volume":"40","author":"SW Zimmerman","year":"1985","unstructured":"Zimmerman SW (1985) Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. Nephron 40:241\u2013245. https:\/\/doi.org\/10.1159\/000183469","journal-title":"Nephron"},{"key":"6643_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/000992289903801009","volume":"38","author":"M Sharma","year":"1999","unstructured":"Sharma M, Sharma R, McCarthy E, Savin V (1999) The FSGS factor: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. Clin Pediatr (Phila) 38:615\u2013616. https:\/\/doi.org\/10.1177\/000992289903801009","journal-title":"Clin Pediatr (Phila)"},{"key":"6643_CR13","first-page":"32","volume":"22","author":"SW Zimmerman","year":"1984","unstructured":"Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22:32\u201338","journal-title":"Clin Nephrol"},{"key":"6643_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1681\/ASN.V93433","volume":"9","author":"ET Mccarthy","year":"1998","unstructured":"Mccarthy ET, Sharma R, Sharma M et al (1998) TNF-\u03b1 increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 9:433\u2013438. https:\/\/doi.org\/10.1681\/ASN.V93433","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.kint.2019.02.013","volume":"96","author":"J M\u00fcller-Deile","year":"2019","unstructured":"M\u00fcller-Deile J, Schenk H, Schroder P et al (2019) Circulating factors cause proteinuria in parabiotic zebrafish. Kidney Int 96:342\u2013349. https:\/\/doi.org\/10.1016\/j.kint.2019.02.013","journal-title":"Kidney Int"},{"key":"6643_CR16","doi-asserted-by":"publisher","first-page":"1247606","DOI":"10.3389\/FIMMU.2023.1247606","volume":"14","author":"G Salfi","year":"2023","unstructured":"Salfi G, Casiraghi F, Remuzzi G (2023) Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis. Front Immunol 14:1247606. https:\/\/doi.org\/10.3389\/FIMMU.2023.1247606","journal-title":"Front Immunol"},{"key":"6643_CR17","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/S00467-023-05928-8","volume":"38","author":"S Hayward","year":"2023","unstructured":"Hayward S, Parmesar K, Saleem MA (2023) What is circulating factor disease and how is it currently explained? Pediatr Nephrol 38:3513\u20133518. https:\/\/doi.org\/10.1007\/S00467-023-05928-8","journal-title":"Pediatr Nephrol"},{"key":"6643_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000415370","volume":"67","author":"WW Bakker","year":"1988","unstructured":"Bakker WW, van Baller JF, LW, (1988) A kallikrein-like molecule and plasma vasoactivity in minimal change disease. Increased turnover in relapse versus remission. Contrib Nephrol 67:31\u201336","journal-title":"Contrib Nephrol"},{"key":"6643_CR19","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1681\/ASN.V1081700","volume":"10","author":"PK Cheung","year":"1999","unstructured":"Cheung PK, Stulp B, Immenschuh S et al (1999) Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 10:1700\u20131708. https:\/\/doi.org\/10.1681\/ASN.V1081700","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR20","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1046\/j.1523-1755.2000.00996.x","volume":"57","author":"PK Cheung","year":"2000","unstructured":"Cheung PK, Klok PA, Baller JFW, Bakker WW (2000) Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57:1512\u20131520. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00996.x","journal-title":"Kidney Int"},{"key":"6643_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","volume":"20","author":"WW Bakker","year":"2005","unstructured":"Bakker WW, van Dael CML, Pierik LJWM et al (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20:1410\u20131415. https:\/\/doi.org\/10.1007\/s00467-005-1936-3","journal-title":"Pediatr Nephrol"},{"key":"6643_CR22","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1681\/ASN.2007080940","volume":"19","author":"R Lennon","year":"2008","unstructured":"Lennon R, Singh A, Welsh GI et al (2008) Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol 19:2140\u20132149. https:\/\/doi.org\/10.1681\/ASN.2007080940","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin JC (2016) The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol 31:207\u2013215. https:\/\/doi.org\/10.1007\/s00467-015-3082-x","journal-title":"Pediatr Nephrol"},{"key":"6643_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/NRM977","volume":"3","author":"F Blasi","year":"2002","unstructured":"Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932\u2013943. https:\/\/doi.org\/10.1038\/NRM977","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6643_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952\u2013960. https:\/\/doi.org\/10.1038\/nm.2411","journal-title":"Nat Med"},{"key":"6643_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/NM1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, M\u00f6ller CC, Altintas MM et al (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363. https:\/\/doi.org\/10.1038\/NM1696","journal-title":"Nat Med"},{"key":"6643_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/KI.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Bajpai J, Saini S et al (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85:649\u2013658. https:\/\/doi.org\/10.1038\/KI.2013.546","journal-title":"Kidney Int"},{"key":"6643_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/KI.2013.549","volume":"85","author":"D Schl\u00f6ndorff","year":"2014","unstructured":"Schl\u00f6ndorff D (2014) Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS? Kidney Int 85:499\u2013501. https:\/\/doi.org\/10.1038\/KI.2013.549","journal-title":"Kidney Int"},{"key":"6643_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0002-9440(10)63354-8","volume":"165","author":"S Lehtonen","year":"2004","unstructured":"Lehtonen S, Lehtonen E, Kudlicka K et al (2004) Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin. Am J Pathol 165:923\u2013936. https:\/\/doi.org\/10.1016\/S0002-9440(10)63354-8","journal-title":"Am J Pathol"},{"key":"6643_CR30","doi-asserted-by":"publisher","first-page":"e0219353","DOI":"10.1371\/journal.pone.0219353","volume":"14","author":"S Beaudreuil","year":"2019","unstructured":"Beaudreuil S, Zhang X, Herr F et al (2019) Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation. PLoS ONE 14:e0219353. https:\/\/doi.org\/10.1371\/journal.pone.0219353","journal-title":"PLoS ONE"},{"key":"6643_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3389\/fimmu.2020.00875","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Herr F, Vernochet A et al (2020) CASK, the soluble glomerular permeability factor, is secreted by macrophages in patients with recurrent focal and segmental glomerulosclerosis. Front Immunol 11:875. https:\/\/doi.org\/10.3389\/fimmu.2020.00875","journal-title":"Front Immunol"},{"key":"6643_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.trsl.2008.04.001","volume":"151","author":"VJ Savin","year":"2008","unstructured":"Savin VJ, McCarthy ET, Sharma R et al (2008) Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Trans Res 151:288\u2013292. https:\/\/doi.org\/10.1016\/j.trsl.2008.04.001","journal-title":"Trans Res"},{"key":"6643_CR33","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/S00467-013-2539-Z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131\u20132135. https:\/\/doi.org\/10.1007\/S00467-013-2539-Z","journal-title":"Pediatr Nephrol"},{"key":"6643_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3978\/J.ISSN.2305-5839.2015.11.08","volume":"3","author":"C Wei","year":"2015","unstructured":"Wei C, Sigdel TK, Sarwal MM, Reiser J (2015) Circulating CD40 autoantibody and suPAR synergy drives glomerular injury. Ann Transl Med 3:300. https:\/\/doi.org\/10.3978\/J.ISSN.2305-5839.2015.11.08","journal-title":"Ann Transl Med"},{"key":"6643_CR35","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","volume":"6","author":"M Delville","year":"2014","unstructured":"Delville M, Sigdel TK, Wei C et al (2014) A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6:256ra136. https:\/\/doi.org\/10.1126\/scitranslmed.3008538","journal-title":"Sci Transl Med"},{"key":"6643_CR36","doi-asserted-by":"publisher","first-page":"e0188045","DOI":"10.1371\/journal.pone.0188045","volume":"12","author":"S Doublier","year":"2017","unstructured":"Doublier S, Zennaro C, Musante L et al (2017) Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS. PLoS ONE 12:e0188045. https:\/\/doi.org\/10.1371\/journal.pone.0188045","journal-title":"PLoS ONE"},{"key":"6643_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/S00467-003-1122-4","volume":"18","author":"A Bakr","year":"2003","unstructured":"Bakr A, Shokeir M, El-Chenawi F et al (2003) Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol 18:516\u2013520. https:\/\/doi.org\/10.1007\/S00467-003-1122-4","journal-title":"Pediatr Nephrol"},{"key":"6643_CR38","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/S00467-012-2163-3","volume":"27","author":"M Bitzan","year":"2012","unstructured":"Bitzan M, Babayeva S, Vasudevan A et al (2012) TNF\u03b1 pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and \u03b23 integrin activation. Pediatr Nephrol 27:2217\u20132226. https:\/\/doi.org\/10.1007\/S00467-012-2163-3","journal-title":"Pediatr Nephrol"},{"key":"6643_CR39","doi-asserted-by":"publisher","first-page":"e0216426","DOI":"10.1371\/journal.pone.0216426","volume":"14","author":"CF Chung","year":"2019","unstructured":"Chung CF, Kitzler T, Kachurina N et al (2019) Intrinsic tumor necrosis factor-\u03b1 pathway is activated in a subset of patients with focal segmental glomerulosclerosis. PLoS ONE 14:e0216426. https:\/\/doi.org\/10.1371\/journal.pone.0216426","journal-title":"PLoS ONE"},{"key":"6643_CR40","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, Von Gersdorff G, Loos M et al (2004) Induction of B7\u20131 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390\u20131397. https:\/\/doi.org\/10.1172\/JCI20402","journal-title":"J Clin Invest"},{"key":"6643_CR41","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"C-C Yu","year":"2013","unstructured":"Yu C-C, Fornoni A, Weins A et al (2013) Abatacept in B7\u20131-positive proteinuric kidney disease. N Engl J Med 369:2416\u20132423. https:\/\/doi.org\/10.1056\/NEJMoa1304572","journal-title":"N Engl J Med"},{"key":"6643_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1053\/J.AJKD.2014.07.023","volume":"64","author":"CP Larsen","year":"2014","unstructured":"Larsen CP, Messias NC, Walker PD (2014) B7\u20131 immunostaining in proteinuric kidney disease. Am J Kidney Dis 64:1001\u20131003. https:\/\/doi.org\/10.1053\/J.AJKD.2014.07.023","journal-title":"Am J Kidney Dis"},{"key":"6643_CR43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G et al (2022) Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol 33:238\u2013252. https:\/\/doi.org\/10.1681\/ASN.2021060794","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/J.KINT.2023.11.022","volume":"105","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Ishizuka K et al (2024) A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int 105:608\u2013617. https:\/\/doi.org\/10.1016\/J.KINT.2023.11.022","journal-title":"Kidney Int"},{"key":"6643_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa2314471","volume":"391","author":"FE Hengel","year":"2024","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M et al (2024) Autoantibodies targeting nephrin in podocytopathies. N Engl J Med 391:422\u2013433. https:\/\/doi.org\/10.1056\/NEJMoa2314471","journal-title":"N Engl J Med"},{"key":"6643_CR46","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/EMBOJ\/20.7.1692","volume":"20","author":"H Plun-Favreau","year":"2001","unstructured":"Plun-Favreau H, Elson G, Chabbert M et al (2001) The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine. EMBO J 20:1692\u20131703. https:\/\/doi.org\/10.1093\/EMBOJ\/20.7.1692","journal-title":"EMBO J"},{"key":"6643_CR47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.imlet.2013.07.005","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Wu T, Chen M et al (2013) The CD40\/CD40L system: a new therapeutic target for disease. Immunol Lett 153:58\u201361. https:\/\/doi.org\/10.1016\/J.imlet.2013.07.005","journal-title":"Immunol Lett"},{"key":"6643_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/S00467-022-05549-7","volume":"38","author":"GW Burke","year":"2023","unstructured":"Burke GW, Chandar J, Sageshima J et al (2023) Benefit of B7\u20131 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal. Pediatr Nephrol 38:145\u2013159. https:\/\/doi.org\/10.1007\/S00467-022-05549-7","journal-title":"Pediatr Nephrol"},{"key":"6643_CR49","doi-asserted-by":"publisher","first-page":"108869","DOI":"10.1016\/J.clim.2021.108869","volume":"232","author":"Q Ye","year":"2021","unstructured":"Ye Q, Zhou C, Wang D et al (2021) Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies. Clin Immunol 232:108869. https:\/\/doi.org\/10.1016\/J.clim.2021.108869","journal-title":"Clin Immunol"},{"key":"6643_CR50","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1681\/ASN.V361260","volume":"3","author":"VJ Savin","year":"1992","unstructured":"Savin VJ, Sharma R, Lovell HBWD (1992) Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3:1260\u20131269. https:\/\/doi.org\/10.1681\/ASN.V361260","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR51","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199604043341402","volume":"334","author":"VJ Savin","year":"1996","unstructured":"Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878\u2013883. https:\/\/doi.org\/10.1056\/NEJM199604043341402","journal-title":"N Engl J Med"},{"key":"6643_CR52","doi-asserted-by":"publisher","first-page":"F1049","DOI":"10.1152\/AJPRENAL.00311.2015","volume":"309","author":"F Fan","year":"2015","unstructured":"Fan F, Chen CCA, Zhang J et al (2015) Fluorescence dilution technique for measurement of albumin reflection coefficient in isolated glomeruli. Am J Physiol Renal Physiol 309:F1049\u2013F1059. https:\/\/doi.org\/10.1152\/AJPRENAL.00311.2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"6643_CR53","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.kint.2017.12.003","volume":"93","author":"S Desideri","year":"2018","unstructured":"Desideri S, Onions KL, Qiu Y et al (2018) A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli. Kidney Int 93:1086\u20131097. https:\/\/doi.org\/10.1016\/j.kint.2017.12.003","journal-title":"Kidney Int"},{"key":"6643_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/1615-9861(200202)2:2<197::aid-prot197>3.0.co;2-6","volume":"2","author":"L Musante","year":"2002","unstructured":"Musante L, Candiano G, Bruschi M et al (2002) Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2:197\u2013205. https:\/\/doi.org\/10.1002\/1615-9861(200202)2:2%3c197::aid-prot197%3e3.0.co;2-6","journal-title":"Proteomics"},{"key":"6643_CR55","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/j.1523-1755.2004.00659.x","volume":"65","author":"EM Weissinger","year":"2004","unstructured":"Weissinger EM, Wittke S, Kaiser T et al (2004) Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 65:2426\u20132434. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00659.x","journal-title":"Kidney Int"},{"key":"6643_CR56","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1681\/ASN.2006050486","volume":"17","author":"G Candiano","year":"2006","unstructured":"Candiano G, Musante L, Bruschi M et al (2006) Repetitive fragmentation products of albumin and \u03b11-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 17:3139\u20133148. https:\/\/doi.org\/10.1681\/ASN.2006050486","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1600-6143.2012.04338.x","volume":"13","author":"J Lopez-Hellin","year":"2013","unstructured":"Lopez-Hellin J, Cantarell C, Jimeno L et al (2013) A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation. Am J Transplant 13:493\u2013500. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04338.x","journal-title":"Am J Transplant"},{"key":"6643_CR58","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00467-019-04289-5","volume":"34","author":"AJ Clark","year":"2019","unstructured":"Clark AJ, Jabs K, Hunley TE et al (2019) Urinary apolipoprotein AI in children with kidney disease. Pediatr Nephrol 34:2351\u20132360. https:\/\/doi.org\/10.1007\/s00467-019-04289-5","journal-title":"Pediatr Nephrol"},{"key":"6643_CR59","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41598-020-58197-y","volume":"10","author":"C Jacobs-Cach\u00e1","year":"2020","unstructured":"Jacobs-Cach\u00e1 C, Puig-Gay N, Helm D et al (2020) A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis. Sci Rep 10:1159. https:\/\/doi.org\/10.1038\/s41598-020-58197-y","journal-title":"Sci Rep"},{"key":"6643_CR60","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/J.KINT.2022.10.023","volume":"103","author":"LH Mariani","year":"2023","unstructured":"Mariani LH, Eddy S, Al Akwaa FM et al (2023) Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney Int 103:565\u2013579. https:\/\/doi.org\/10.1016\/J.KINT.2022.10.023","journal-title":"Kidney Int"},{"key":"6643_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/excr.1997.3739","volume":"236","author":"P Mundel","year":"1997","unstructured":"Mundel P, Reiser J, Borja AZM et al (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236:248\u2013258. https:\/\/doi.org\/10.1006\/excr.1997.3739","journal-title":"Exp Cell Res"},{"key":"6643_CR62","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, O\u2019Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630\u2013638. https:\/\/doi.org\/10.1681\/ASN.V133630","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR63","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJM Coward","year":"2005","unstructured":"Coward RJM, Foster RR, Patton D et al (2005) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16:629\u2013637. https:\/\/doi.org\/10.1681\/ASN.2004030172","journal-title":"J Am Soc Nephrol"},{"key":"6643_CR64","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00467-011-1831-z","volume":"26","author":"S Babayeva","year":"2011","unstructured":"Babayeva S, Miller M, Zilber Y et al (2011) Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes. Pediatr Nephrol 26:1071\u20131081. https:\/\/doi.org\/10.1007\/s00467-011-1831-z","journal-title":"Pediatr Nephrol"},{"key":"6643_CR65","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/path.4149","volume":"229","author":"JJ Harris","year":"2013","unstructured":"Harris JJ, McCarthy HJ, Ni L et al (2013) Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1. J Pathol 229:660\u2013671. https:\/\/doi.org\/10.1002\/path.4149","journal-title":"J Pathol"},{"key":"6643_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.kint.2023.02.031","volume":"104","author":"CJ May","year":"2023","unstructured":"May CJ, Chesor M, Hunter SE et al (2023) Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events. Kidney Int 104:265\u2013278. https:\/\/doi.org\/10.1016\/j.kint.2023.02.031","journal-title":"Kidney Int"},{"key":"6643_CR67","doi-asserted-by":"publisher","first-page":"F1148","DOI":"10.1152\/ajprenal.00349.2015","volume":"310","author":"N Kachurina","year":"2016","unstructured":"Kachurina N, Chung CF, Benderoff E et al (2016) Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis. Am J Physiol Renal Physiol 310:F1148\u2013F1156. https:\/\/doi.org\/10.1152\/ajprenal.00349.2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"6643_CR68","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00467-018-3995-2","volume":"33","author":"TM Kitzler","year":"2018","unstructured":"Kitzler TM, Kachurina N, Bitzan MM et al (2018) Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome. Pediatr Nephrol 33:1741\u20131750. https:\/\/doi.org\/10.1007\/s00467-018-3995-2","journal-title":"Pediatr Nephrol"},{"key":"6643_CR69","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.kint.2018.10.030","volume":"95","author":"P Srivastava","year":"2019","unstructured":"Srivastava P, Solanki AK, Arif E et al (2019) Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int 95:708\u2013716. https:\/\/doi.org\/10.1016\/j.kint.2018.10.030","journal-title":"Kidney Int"},{"key":"6643_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/PATH.3964","volume":"226","author":"AH Salmon","year":"2012","unstructured":"Salmon AH, Satchell SC (2012) Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 226:562\u2013574. https:\/\/doi.org\/10.1002\/PATH.3964","journal-title":"J Pathol"},{"key":"6643_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2016.02.013","volume":"86","author":"M Li","year":"2016","unstructured":"Li M, Corbelli A, Watanabe S et al (2016) Three-dimensional podocyte\u2013endothelial cell co-cultures: assembly, validation, and application to drug testing and intercellular signaling studies. Eur J Pharm Sci 86:1\u201312. https:\/\/doi.org\/10.1016\/j.ejps.2016.02.013","journal-title":"Eur J Pharm Sci"},{"key":"6643_CR72","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40620-019-00683-2","volume":"33","author":"M Li","year":"2020","unstructured":"Li M, Alfieri CM, Morello W et al (2020) Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier. J Nephrol 33:747\u2013755. https:\/\/doi.org\/10.1007\/s40620-019-00683-2","journal-title":"J Nephrol"},{"key":"6643_CR73","doi-asserted-by":"publisher","first-page":"F659","DOI":"10.1152\/ajprenal.00097.2021","volume":"321","author":"FK Eroglu","year":"2021","unstructured":"Eroglu FK, Yazar V, Guler U et al (2021) Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes. Am J Physiol Renal Physiol 321:F659\u2013F673. https:\/\/doi.org\/10.1152\/ajprenal.00097.2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"6643_CR74","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C et al (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46. https:\/\/doi.org\/10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"key":"6643_CR75","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","volume":"87","author":"LJ Hickson","year":"2009","unstructured":"Hickson LJ, Gera M, Amer H et al (2009) Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 87:1232\u20131239. https:\/\/doi.org\/10.1097\/TP.0b013e31819f12be","journal-title":"Transplantation"},{"key":"6643_CR76","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/TP.0000000000002008","volume":"102","author":"S Alasfar","year":"2018","unstructured":"Alasfar S, Matar D, Montgomery RA et al (2018) Rituximab and therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis post kidney transplantation. Transplantation 102:e115\u2013e120. https:\/\/doi.org\/10.1097\/TP.0000000000002008","journal-title":"Transplantation"},{"key":"6643_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.scr.2016.06.001","volume":"17","author":"O Ciampi","year":"2016","unstructured":"Ciampi O, Iacone R, Longaretti L et al (2016) Generation of functional podocytes from human induced pluripotent stem cells. Stem Cell Res 17:130\u2013139. https:\/\/doi.org\/10.1016\/j.scr.2016.06.001","journal-title":"Stem Cell Res"},{"key":"6643_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1089\/crispr.2018.0048","volume":"2","author":"P Trionfini","year":"2019","unstructured":"Trionfini P, Ciampi O, Todeschini M et al (2019) CRISPR-Cas9-mediated correction of the G189R-PAX2 mutation in induced pluripotent stem cells from a patient with focal segmental glomerulosclerosis. CRISPR J 2:108\u2013120. https:\/\/doi.org\/10.1089\/crispr.2018.0048","journal-title":"CRISPR J"},{"key":"6643_CR79","doi-asserted-by":"publisher","first-page":"101878","DOI":"10.1016\/j.scr.2020.101878","volume":"46","author":"G Menara","year":"2020","unstructured":"Menara G, Lefort N, Antignac C, Mollet G (2020) Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from a patient with steroid-resistant nephrotic syndrome carrying the homozygous p.R138Q mutation in the podocin-encoding NPHS2 gene. Stem Cell Res 46:101878. https:\/\/doi.org\/10.1016\/j.scr.2020.101878","journal-title":"Stem Cell Res"},{"key":"6643_CR80","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.scr.2019.101661","volume":"41","author":"X Gao","year":"2019","unstructured":"Gao X, Gao X, Zhao H et al (2019) Establishment of induced pluripotent stem cell line (GSPHi001-A) from a 6-year-old female with nephrotic syndrome. Stem Cell Res 41:101661. https:\/\/doi.org\/10.1016\/j.scr.2019.101661","journal-title":"Stem Cell Res"},{"key":"6643_CR81","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1038\/s41467-018-07594-z","volume":"9","author":"LJ Hale","year":"2018","unstructured":"Hale LJ, Howden SE, Phipson B et al (2018) 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening. Nat Commun 9:5167. https:\/\/doi.org\/10.1038\/s41467-018-07594-z","journal-title":"Nat Commun"},{"key":"6643_CR82","doi-asserted-by":"publisher","first-page":"e122697","DOI":"10.1172\/jci.insight.122697","volume":"4","author":"JL Harder","year":"2019","unstructured":"Harder JL, Menon R, Otto EA et al (2019) Organoid single cell profiling identifies a transcriptional signature of glomerular disease. JCI Insight 4:e122697. https:\/\/doi.org\/10.1172\/jci.insight.122697","journal-title":"JCI Insight"},{"key":"6643_CR83","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1101\/GAD.329573.119","volume":"33","author":"MH Little","year":"2019","unstructured":"Little MH, Combes AN (2019) Kidney organoids: accurate models or fortunate accidents. Genes Dev 33:1319\u20131345. https:\/\/doi.org\/10.1101\/GAD.329573.119","journal-title":"Genes Dev"},{"key":"6643_CR84","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ndt\/gfx214","volume":"33","author":"L Allard","year":"2018","unstructured":"Allard L, Kwon T, Krid S et al (2018) Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort. Nephrol Dial Transplant 33:954\u2013963. https:\/\/doi.org\/10.1093\/ndt\/gfx214","journal-title":"Nephrol Dial Transplant"},{"key":"6643_CR85","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ajt.2023.12.010","volume":"24","author":"A Angeletti","year":"2024","unstructured":"Angeletti A, Bin S, Magnasco A et al (2024) Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 24:688\u2013692. https:\/\/doi.org\/10.1016\/j.ajt.2023.12.010","journal-title":"Am J Transplant"},{"key":"6643_CR86","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.trsl.2015.03.002","volume":"166","author":"M Sharma","year":"2015","unstructured":"Sharma M, Zhou J, Gauchat JF et al (2015) Janus kinase 2\/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier. Transl Res 166:384\u2013398. https:\/\/doi.org\/10.1016\/j.trsl.2015.03.002","journal-title":"Transl Res"},{"key":"6643_CR87","doi-asserted-by":"publisher","first-page":"315","DOI":"10.21037\/ATM-22-3670","volume":"11","author":"P Rashmi","year":"2023","unstructured":"Rashmi P, Sigdel TK, Rychkov D et al (2023) Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors. Ann Transl Med 11:315\u2013315. https:\/\/doi.org\/10.21037\/ATM-22-3670","journal-title":"Ann Transl Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06643-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:58:18Z","timestamp":1757131098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06643-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6643"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06643-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}